Investor Presentaiton

II Key Investment Highlights 2 Attractive Industry Dynamics (II/III) A highly defensive sector with significant room for continued growth Total Market Size¹ | EGP bn וי Egypt's healthcare market is the fastest growing in the region driven by significant growth in the pharmaceuticals market Market Segmentation CAGR: 17% 14.5 % 92 21% 111 31.1 % 13.8 % 24% 26 74 21% 61 28 26.0 % 50k Active Pharmacies 17.1 % 44.1 2.2 k Hospitals % 75 20% 16% 51 24 13% 44 20 39 28.4 % 25.0 % 19 16 14 64 50 41 32 25 28 2013 2014 2015 2016 Retail 2017 Non Retail Market Volume Evolution | in Millions CAGR 4% 2018 2019 Average Selling Price (ASP) Evolution Cairo & Canal Delta Upper Egypt Alexandria Key Growth Drivers Drop in production awaiting price increase Y-o-y growth 10% CAGR: 15% Normalized CAGR 10% Y-o-y growth 11% Ageing & Growing Population Increase of Chronic Diseases Increasing Generic Uptake 31.7 28.6 3,172 3,490 26.0 3,186 2,670 2,891 3,035 2,849 4.4 GENERIC 72 14.5 15.3 16.5 19.3 1.3 Pricing Adjustment Waves Higher Priced Drug Replacements New Products New Markets 3,100 18.0 21.5 2013 2014 2015 2016 2017 2018 2019 2013 Normalized ASP Normalized Volume Overstock Effect 2014 2015 2016 2017 2018 2019 Price Adjustment Waves In 2016, Increase in price of medicine that cost less than EGP 30 by 20% due to increase in production costs In 2017, Retail price increase of 30-50% for over 3K SKUs ibnsinapharma 1) Non-retail market data (tenders, wholesale, private hospitals) published by IMS Health is based on the use of end-user price in calculating the value of the market. Tenders typically see significantly lower prices than those prevailing in the retail segment, while prices vary from one tender to another. Source: IMS Health, BMI, WHO, Company Management 13

View entire presentation